ChemFaces is a professional high-purity natural products manufacturer.
Product Intended Use
1. Reference standards
2. Pharmacological research
Citing Use of our Products
How to Order
Orders via your E-mail:
1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Sent to Email: firstname.lastname@example.org
Order & Inquiry & Tech Support
Address: No. 83, CheCheng Rd., WETDZ, Wuhan, Hubei 430056, PRC
Delivery & Payment method
1. Usually delivery time: Next day delivery by 9:00 a.m. Order now
2. We accept: Wire transfer & Credit card & Paypal & Western Union
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
|Size /Price /Stock
||10 mM * 1 mL in DMSO / $8.9 / In-stock||Other Packaging
||*Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
More articles cited ChemFaces products.
BMC Complement Altern Med.2014, 14:352Int J Mol Sci. 2014, 15(5):8443-57Sci. Rep.2015, 14-23China Pharmacy2015, 26(27)Evid Based Complement Alternat Me...2016...Acta Physiologiae Plantarum2016, 38:7Evid Based Complement Alternat Me...2017...Biochem Biophys Res Commun....2017...
J.Acta Agriculturae Scandinavica...2017...Microchemical Journal2018, 137:168-173Phytochemistry2018, 15:83-92Int J Mol Sci.2018, 19(9):E2681Chem Biol Interact.2018, 290:44-51Korean J Environ Agric....2018...Journal of Third Military Medical...2018...Phytomedicine.2018, 41:62-66
Food Chem.2019, 275:746-753Journal of Apiculture...2019...J Ethnopharmacol.2020, 249:112396Int J Med Sci.2020, 17(5):626-631Molecules.2020, 25(18):4283.Plants (Basel).2020, 9(11):1535.Int Immunopharmacol.2020, 90:107268.
Our products had been exported to the following research institutions and universities, And still growing.
Florida A&M University (USA)University of Pretoria (South Africa)Mahatma Gandhi University (India)Centrum Menselijke Erfelijkheid (Belgium)
University of Amsterdam (Netherlands)Universite Libre de Bruxelles (Belgium)University of Wollongong (Australia)Cancer Research Initatives Foun... (Malaysia)
University of Hawaii Cancer Center (USA)Universiti Kebangsaan Malaysia (Malaysia)Biotech R&D Institute (USA)
Inquire / Order:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Mol Med Rep.2014, 9(5):1653-9Analytical sci. & Tech2020, 33(5):224-231Chem. of Vegetable Raw Materials2020, 97-105Food Chem.2016, 191:81-90Food Chem.2019, 278:683-691Molecules.2018, 23(10):E2638Int J Mol Sci.2020, 21(7):2530.Evid Based Complement Alternat Med.2020, 2020:1970349.J of Applied Pharmaceutical Science2020, 10(1):077-082Oncotarget.2016, 8(51):88386-88400
Related Screening Libraries
||Adenosine is a nucleoside composed of a molecule of adenine attached to a ribose sugar molecule (ribofuranose) moiety via a β-N9-glycosidic bond. Adenosine induces SphK1 activity in human and mouse sickle and normal erythrocytes in vitro, it can activate the neuroimmune system, alter neuronal function and neurotransmission,and contribute to symptoms of sickness and psychopathologies. Adenosine activates mast cells have been long implicated in allergic asthma and studies in rodent mast cells have assigned the A3 Adenosine receptor (A3R) a primary role in mediating Adenosine responses.
||ERK | IL Receptor | VEGFR | cAMP | A3 Adenosine receptor | SphK1|
|Mol Immunol. 2015 May;65(1):25-33. |
|Down-regulation of the A3 adenosine receptor in human mast cells upregulates mediators of angiogenesis and remodeling.[Pubmed: 25597247]|
|Adenosine activated mast cells have been long implicated in allergic asthma and studies in rodent mast cells have assigned the A3 Adenosine receptor (A3R) a primary role in mediating Adenosine responses.
METHODS AND RESULTS:
Here we analyzed the functional impact of A3R activation on genes that are implicated in tissue remodeling in severe asthma in the human mast cell line HMC-1 that shares similarities with lung derived human mast cells. Quantitative real time PCR demonstrated upregulation of IL6, IL8, VEGF, amphiregulin and osteopontin. Moreover, further upregulation of these genes was noted upon the addition of dexamethasone. Unexpectedly, activated A3R down regulated its own expression and knockdown of the receptor replicated the pattern of agonist induced gene upregulation.
This study therefore identifies the human mast cell A3R as regulator of tissue remodeling gene expression in human mast cells and demonstrates a heretofore-unrecognized mode of feedback regulation that is exerted by this receptor.
|J Neurochem. 2015 Jan;132(1):51-60. |
|Adenosine transiently modulates stimulated dopamine release in the caudate-putamen via A1 receptors.[Pubmed: 25219576]|
|Adenosine modulates dopamine in the brain via A1 and A2A receptors, but that modulation has only been characterized on a slow time scale. Recent studies have characterized a rapid signaling mode of Adenosine that suggests a possible rapid modulatory role.
METHODS AND RESULTS:
Here, fast-scan cyclic voltammetry was used to characterize the extent to which transient Adenosine changes modulate stimulated dopamine release (5 pulses at 60 Hz) in rat caudate-putamen brain slices. Exogenous Adenosine was applied and dopamine concentration monitored. Adenosine only modulated dopamine when it was applied 2 or 5 s before stimulation. Longer time intervals and bath application of 5 μM Adenosine did not decrease dopamine release. Mechanical stimulation of endogenous Adenosine 2 s before dopamine stimulation also decreased stimulated dopamine release by 41 ± 7%, similar to the 54 ± 6% decrease in dopamine after exogenous Adenosine application. Dopamine inhibition by transient Adenosine was recovered within 10 min. The A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine blocked the dopamine modulation, whereas dopamine modulation was unaffected by the A2A receptor antagonist SCH 442416. Thus, transient Adenosine changes can transiently modulate phasic dopamine release via A1 receptors. These data demonstrate that Adenosine has a rapid, but transient, modulatory role in the brain. Here, transient Adenosine was shown to modulate phasic dopamine release on the order of seconds by acting at the A1 receptor. However, sustained increases in Adenosine did not regulate phasic dopamine release.
This study demonstrates for the first time a transient, neuromodulatory function of rapid Adenosine to regulate rapid neurotransmitter release.
|Blood. 2015 Mar 5;125(10):1643-52. |
|Elevated adenosine signaling via adenosine A2B receptor induces normal and sickle erythrocyte sphingosine kinase 1 activity.[Pubmed: 25587035]|
|Erythrocyte possesses high sphingosine kinase 1 (SphK1) activity and is the major cell type supplying plasma sphingosine-1-phosphate, a signaling lipid regulating multiple physiological and pathological functions.
Recent studies revealed that erythrocyte SphK1 activity is upregulated in sickle cell disease (SCD) and contributes to sickling and disease progression. However, how erythrocyte SphK1 activity is regulated remains unknown.
METHODS AND RESULTS:
Here we report that Adenosine induces SphK1 activity in human and mouse sickle and normal erythrocytes in vitro. Next, using 4 Adenosine receptor-deficient mice and pharmacological approaches, we determined that the A2B Adenosine receptor (ADORA2B) is essential for Adenosine-induced SphK1 activity in human and mouse normal and sickle erythrocytes in vitro. Subsequently, we provide in vivo genetic evidence that Adenosine deaminase (ADA) deficiency leads to excess plasma Adenosine and elevated erythrocyte SphK1 activity. Lowering Adenosine by ADA enzyme therapy or genetic deletion of ADORA2B significantly reduced excess Adenosine-induced erythrocyte SphK1 activity in ADA-deficient mice. Finally, we revealed that protein kinase A-mediated extracellular signal-regulated kinase 1/2 activation functioning downstream of ADORA2B underlies Adenosine-induced erythrocyte SphK1 activity.
Overall, our findings reveal a novel signaling network regulating erythrocyte SphK1 and highlight innovative mechanisms regulating SphK1 activity in normal and SCD.
|Metabolism. 2014 Dec;63(12):1491-8. |
|Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illness.[Pubmed: 25308443]|
|Adenosine is a pleiotropic bioactive with potent neuromodulatory properties. Due to its ability to easily cross the blood-brain barrier, it can act as a signaling molecule between the periphery and the brain. It functions through four (A1, A2A, A2B, and A3) cell surface G protein-coupled Adenosine receptors (ARs) that are expressed in some combination on nearly all cells types within the CNS. By regulating the activity of adenylyl cyclase and changing the intracellular concentration of cAMP, Adenosine can alter neuronal function and neurotransmission. A variety of illnesses related to metabolic dysregulation, such as type 1 diabetes and Alzheimer's disease, are associated with an elevated serum concentration of Adenosine and a pathogenesis rooted in inflammation.
This review describes the accepted physiologic function of Adenosine in neurological disease and explores its new potential as a peripheral to central danger signal that can activate the neuroimmune system and contribute to symptoms of sickness and psychopathologies.
||The rhizomes of Typhonium giganteum Engl.
||DMSO, Pyridine, Methanol, Ethanol, etc.
||Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: email@example.com
||The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
ChemFaces New Products and Compounds
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)PMID: 29328914
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)PMID: 32004475
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)PMID: 29149595
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)PMID: 29553709
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)PMID: 28005066
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
|Nat. Rev. Drug Discov., 2008, 7(9):759-70. |
|Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.[Reference: WebLink]|
|Adenosine is a key endogenous molecule that regulates tissue function by activating four G-protein-coupled Adenosine receptors: A1, A2A, A2B and A3.
METHODS AND RESULTS:
Cells of the immune system express these receptors and are responsive to the modulatory effects of Adenosine in an inflammatory environment. Animal models of asthma, ischaemia, arthritis, sepsis, inflammatory bowel disease and wound healing have helped to elucidate the regulatory roles of the various Adenosine receptors in dictating the development and progression of disease.
This recent heightened awareness of the role of Adenosine in the control of immune and inflammatory systems has generated excitement regarding the potential use of Adenosine-receptor-based therapies in the treatment of infection, autoimmunity, ischaemia and degenerative diseases.
|Circulation. 2015 Feb 24;131(8):730-41. |
|Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia.[Pubmed: 25538227]|
|Preeclampsia is a prevalent hypertensive disorder of pregnancy and a leading cause of maternal and neonatal morbidity and mortality worldwide. This pathogenic condition is speculated to be caused by placental abnormalities that contribute to the maternal syndrome. However, the specific factors and signaling pathways that lead to impaired placentas and maternal disease development remain elusive.
Using 2 independent animal models of preeclampsia (genetically engineered pregnant mice with elevated Adenosine exclusively in placentas and a pathogenic autoantibody-induced preeclampsia mouse model), we demonstrated that chronically elevated placental Adenosine was sufficient to induce hallmark features of preeclampsia, including hypertension, proteinuria, small fetuses, and impaired placental vasculature. Genetic and pharmacological approaches revealed that elevated placental Adenosine coupled with excessive A₂B Adenosine receptor (ADORA2B) signaling contributed to the development of these features of preeclampsia. Mechanistically, we provided both human and mouse evidence that elevated placental CD73 is a key enzyme causing increased placental Adenosine, thereby contributing to preeclampsia.
We determined that elevated placental Adenosine signaling is a previously unrecognized pathogenic factor for preeclampsia. Moreover, our findings revealed the molecular basis underlying the elevation of placental Adenosine and the detrimental role of excess placental Adenosine in the pathophysiology of preeclampsia, and thereby, we highlight novel therapeutic targets.